1. Introduction
===============

Measles is a common disease in children, and is responsible for a large number of deaths among children worldwide ([@b1-epj-09-3997], [@b2-epj-09-3997]). Vaccination against measles can significantly reduce the rate of infection among children ([@b3-epj-09-3997]). Loss of high levels of immunity against measles among children causes outbreaks ([@b4-epj-09-3997]). In the global meeting for children in 1990, some main objectives were determined to be followed by different regions of the world which included; 90% decrease in complication of measles, 95% decrease in mortality from measles, and eradication of measles ([@b5-epj-09-3997]). The deadline for reaching the objectives was the year 2000 for the USA, 2007 for Europe, and 2010 for EMRO countries ([@b5-epj-09-3997]). Vaccination is the main part of the measles eradication program ([@b6-epj-09-3997], [@b7-epj-09-3997]). In 2000, the WHO, UNICEF, the US Department of Health and Human Services and Centers for Diseases Control and Prevention (CDC) recommended improving the measles vaccination program and surveillance of the measles eradication program. One main strategy specified was the two times vaccination of children. According to the protocols, the first dose was injected in 12--15 months' children and the second dose was injected in 18--24 months' children and has continued since 2001 in Europe ([@b8-epj-09-3997]). In Iran, a global vaccination program was established using a Measles, Rubella (MR) vaccine for around 30 million of the 5--25 years-old population with the objective of measles eradication in 2003 ([@b9-epj-09-3997]). Afterwards, the vaccination program was changed to a Mumps, Measles, and Rubella (MMR) vaccine and was injected two times; once in 12 months after birth and then at 4--6 years of age. Later, according to the 7th edition of "Iran National Immunization Program", the time of the vaccination program changed to 12 months and 18 months after birth in 2009--2010. After a mass immunization campaign in 2003, the number of measles cases reduced significantly from 21 cases per 1,000,000 in 2003 to \<1 case per 1,000,000 in 2006, 2007 and 2008, respectively in Iran ([@b9-epj-09-3997], [@b10-epj-09-3997]). However, several outbreaks in measles occurred in Hormozgan in 2009, 2010, 2012 and 2015. The general objective of the current study was to report the outbreaks of measles from 2009 to 2015. The specific objectives of the study were to report the outbreak(s) of measles in Hormozgan according to gender, age groups, nationality, living area, place of residence, contact history and vaccination status.

2. Material and Methods
=======================

This was a cross-sectional study conducted in 2015 in Hormozgan province on the southern coast of Iran. Hormozgan is known to have a hot and humid climate. The study sample included all definite cases of measles from 2006 to 2015. According to the 2009 National Guideline for Measles Surveillance in Elimination Phase, suspected cases are all individuals with fever, rash, cough, and conjunctivitis who should be reported to the Health Center of Hormozgan province. According to this guideline, for suspected cases, IgM serology for measles should be measured. Thus, in this study, we included those cases with positive serology for measles. The study tool was a checklist for each patient. The checklist included demographic information, vaccination status, history of contact with a suspected person, and area of report. To complete the checklists, the available data in the Communicable Disease Surveillance Unit of the Health Center of Hormozgan province were investigated. The study was approved by the ethics committee of Hormozgan University of Medical Sciences (Hormozgan, Iran). The information regarding patients was kept confidential. Also, the information was extracted without patients' names by using codes. Data was analyzed using IBM© SPSS© Statistics version 21 (IBM© Corp., Armonk, NY, USA). Descriptive statistics including mean, standard deviation, frequency and percentage were used for data analysis.

3. Results
==========

[Table 1](#t1-epj-09-3997){ref-type="table"} shows the frequency of suspected and confirmed cases of measles from 2009 to 2015 according to the information reported by the health system. As this table shows, from 2009 to 2015 there were 851 suspected cases of measles, while only 135 people were confirmed cases. We investigated the records of 851 suspected cases of measles, among which 135 definite cases were recognized. As table one shows, 49% of patients were males, 51% were females, 79% were Iranian, 18% were Afghans, and 3% were Indians or Pakistanis. Also, 31% of cases were reported from Bandar Abbas (the capital of Hormozgan Province), 18% were reported from Minab, 18% from Qeshm, 17% from Jask and other cases were reported from other areas of the Hormozgan. 30% of the cases were reported from urban areas, while others were from rural areas (70%). The information regarding the distribution of the patients based on their gender, nationality, place of residence, age, and history of contact with suspected patients is reported in [Table 2](#t2-epj-09-3997){ref-type="table"}. According to [Table 3](#t3-epj-09-3997){ref-type="table"}, from 2009 to 2015, there were 44 cases with adequate vaccination and 91 cases with inadequate or no vaccination. The most cases with inadequate or no vaccination were reported in 2015, 2010 and 2012, respectively. The most cases with adequate vaccination were reported in 2012, 2010 and 2015, respectively.

4. Discussion
=============

During 2006--2015 four outbreaks of measles occurred in Hormozgan province. Since the immunization program in 2005, we have experienced four outbreaks - in years 2009, 2010, 2012, and 2015. As [table 2](#t2-epj-09-3997){ref-type="table"} indicates, fewer cases were reported in 2011 and 2013 due to vaccination of the relatives of definite cases who were discovered by the health surveillance system. One of the priorities of the health system in Iran is to control the diseases that are preventable through vaccination. For reaching the objective of measles eradication, the vaccination coverage of \> 95% is required ([@b5-epj-09-3997]). However, as mentioned, incomplete vaccination in some years, has been a major obstacle in reaching this goal, which leads to outbreaks of the disease in susceptible areas. Also, another issue is the arrival of refugees especially from Afghanistan and Pakistan where a low coverage of vaccination is considered ([@b11-epj-09-3997]). The arrival of refugees can increase the likelihood of an outbreak. In Bandar Abbas 78% of measles cases occurred in individuals without vaccination or with incomplete vaccination in 2009 and 2010 outbreaks, which were similar to European countries. Vaccination coverage of less than 95% of the population was the main cause of measles outbreaks in 2009, 2010, 2012 and 2015. Low vaccination coverage was also the main reason for observing an outbreak of measles in European countries in 2010. Furthermore, similar studies in American and Asian countries confirm the role of vaccination coverage ([@b12-epj-09-3997], [@b13-epj-09-3997]). However, the reported outbreak in European measles cases was fewer in areas with 99% vaccination coverage. Vaccination coverage was 89% and 84% in the first and second vaccination projects respectively in Europe. In this epidemic, between 7,000 and 10,000 cases were reported from France, Italy, and Switzerland. It is important to identify the spatial clusters of measles in order to eliminate measles ([@b14-epj-09-3997]). A similar epidemic occurred in 2006 in Germany and 1,749 cases were reported among which 14% had incomplete vaccination and 80% had no vaccination ([@b4-epj-09-3997]). The information about the vaccination coverage of the areas with high frequency of reported cases is helpful. Cases of measles are still being reported from European countries in spite of routine vaccination in childhood. One study in 2009, reported 12,132 measles cases from 5 countries (Romania, Germany, England, Switzerland, and Italy), among them, 210 were refugees. One fifth of the patients were more than 20 years old. Patients often had incomplete vaccination or reported no vaccination at all. Also, mortality in 5 cases was reported in this study ([@b15-epj-09-3997]). One cause of incomplete vaccination in Germany is that the vaccination is not mandatory in this country. This may also be the reason for the lower number of affected cases in Iran in comparison to Germany. In our study a large percentage of measles cases were reported from Jask. In the 2010 outbreak in Jask, 63% of measles cases and in the 2012 outbreak in Bandar Abbas, 83% of measles cases were reported in patients with complete vaccination, which shows the importance of maintenance of cold continuum for prevention of measles outbreak. Also, most cases were reported from one area with complete vaccination coverage. Unavailability of electrical power, isolation from populated areas, and inappropriate transportation may have interrupted cold continuum. However, another important cause is genetic mutations in the virus which causes outbreaks in a population with high vaccination coverage ([@b16-epj-09-3997], [@b17-epj-09-3997]). According to national protocol in 2008, the second vaccination dose changed from 4--6 years to 18 months, and children between 18 months to 6 years old were exited from active mandatory vaccination in the second phase ([@b6-epj-09-3997]). This may have been a cause of outbreak in 2009 and 2010 in Bandar Abbas. It is shown that two doses of measles vaccination are more effective than a single dose vaccination ([@b18-epj-09-3997]) and timely routine vaccination plays an important role in measles eradication ([@b19-epj-09-3997]). However, the fewer cases of measles in 2011 and 2013, is due to vaccination of the relatives and close contacts of definite cases discovered by health surveillance system. After the outbreak in 2009 and 2010, vaccination in close contact people and universal vaccination was done for all people in the areas with measles outbreak, and no cases were reported after the universal vaccination. One study in Peru confirmed that the efficacy of universal vaccination and the last case of measles occurred 3 weeks after outbreak response immunization ([@b20-epj-09-3997]). Other studies have confirmed the efficacy of outbreak response immunization ([@b21-epj-09-3997]). A large number of cases in recent outbreaks are children less than 1 year old. This could be due to lack of protocol for their vaccination; assuming that they are not at risk of the disease because of maternal immunization. Prevalence of measles increased among children less than 1 year old after 2009, and includes 46% of measles cases in 2015 which is incompatible with hypothesis of immunity of the children less than 1 year against measles by mothers' antibodies. One study in the Netherlands in 2007 confirms our hypothesis and indicates that the duration of the immunity is until 3.5 to 5.5 months after birth ([@b22-epj-09-3997]). After each outbreak, a duration of 1 to 3 years with fewer cases of measles are reported, which is due to immunization of close contact persons in areas with definite measles cases, but this doesn't prevent outbreaks during the following years. Therefore, the coverage and immunogenicity of current vaccination protocol is in doubt.

5. Conclusions
==============

A high percentage of measles cases in rural areas was reported in areas with complete vaccination coverage. This shows interruption of cold continuum. Also, increasing the number of less than 1 year old cases reported could be due to poor nutritional status of the children and insufficient immunization of the mothers. More studies are recommended for finding the causes of interruption of cold continuum. Also, further studies are required for the assessment of immunization in children and mothers. Moreover, it is suggested that vaccination protocols of measles should be considered and modified according to these findings.
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###### 

Frequency of suspected and confirmed cases of measles in 2009--2015

  Variable      2009   2010   2011   2012   2013   2014   2015   2009--2015
  ------------- ------ ------ ------ ------ ------ ------ ------ ------------
  Vaccination   No     No     Yes    No     Yes    Yes    No     \-
  Suspicious    23     154    76     187    151    118    142    851
  Positive      19     29     2      28     7      11     39     135

###### 

Demographic information of the patients in 2009--2015 outbreaks

  Demographic information   Year; n (%)                                                                              
  ------------------------- -------------- ----------- --------- --------- --------- --------- --------- ----------- ----------
  Gender                    Male           9 (47.4)    9 (31)    1 (50)    20 (71)   2 (29)    7 (64)    18 (46)     66 (49)
  Female                    10 (53)        20 (69)     1 (50)    8 (29)    5 (71)    4 (36)    21 (54)   69 (51)     
  Race                      Iranian        14 (74)     24 (83)   2 (100)   24 (86)   7 (100)   6 (55)    36 (92)     113 (84)
  Afghan                    2 (10)         5 (17)      0 (0)     4 (14)    0 (0)     5 (45)    2 (5)     18 (13)     
  Other Races               3 (16)         0 (0)       0 (0)     0 (0)     0 (0)     0 (0)     1 (3)     4 (3)       
  Area                      Urban areas    15 (78.9)   9 (31)    0 (0)     2 (7)     3 (43)    5 (45)    7 (18)      41 (30)
  Rural areas               4 (21.1)       20 (69)     2 (100)   26 (93)   4 (57)    6 (55)    32 (82)   94 (70)     
  Place of residence        Bandar Abbas   16 (84)     7 (25)    0 (0)     12 (43)   1 (14)    1 (9)     5 (13)      42 (31)
  Jask                      0 (0)          16 (55)     0 (0)     0 (0)     0 (0)     1 (9)     6 (15)    23 (17)     
  Minab                     0 (0)          0 (0)       1 (50)    8 (29)    2 (29)    0 (0)     23 (59)   34 (25)     
  Qeshm                     0 (0)          3 (10)      1 (50)    6 (21)    3 (43)    8 (73)    3 (8)     24 (18)     
  Other areas               3 (16)         3 (10)      0 (0)     2 (7)     1 (14)    1 (9)     2 (5)     12 (9)      
  Age group (year)          \< 1           5 (26)      9 (31)    0 (0)     4 (14)    2 (29)    2 (18)    18 (46)     40 (30)
  1--5                      9 (48)         5 (17.3)    1 (50)    6 (22)    1 (14)    0 (0)     4 (10)    26 (19)     
  5--12                     1 (5)          8 (27.6)    0 (0)     12 (42)   1 (14)    1 (9)     5 (13)    28 (21)     
  \> 12                     4 (21%)        7 (24.1)    1 (50)    6 (22)    3 (43)    8 (73)    12 (31)   41 (30)     
  Contact history           Positive       9 (48)      18 (62)   0 (0)     14 (50)   5 (71)    4 (36)    28 (72)     78 (58)
  Negative                  10 (52)        11 (38)     2 (100)   14 (50)   2 (29)    7 (64)    11 (28)   57 (42)     
  Total                     19             29          2         28        7         11        39        135 (100)   

###### 

Vaccination status in patients with confirmed measles in 2009--2015

  Vaccination status during the period (year)   Bandar Abbas   Jask   Minab   Qeshem   Other areas   Total   
  --------------------------------------------- -------------- ------ ------- -------- ------------- ------- ----
  2009                                          Adequate       6      0       0        0             0       6
  Inadequate or no vaccination                  \<             5      0       0        0             0       13
  \>1                                           6              0      0       0        2                     
  2010                                          Adequate       1      10      0        0             1       12
  Inadequate or no vaccination                  \<1            3      2       0        3             1       17
  \>1                                           4              4      0       0        0                     
  2011                                          Adequate       0      0       1        0             0       1
  Inadequate or no vaccination                  \<1            0      0       0        1             0       1
  \>1                                           0              0      0       0        0                     
  2012                                          Adequate       10     0       2        2             0       14
  Inadequate or no vaccination                  \<1            1      0       1        2             1       14
  \>1                                           1              0      5       2        1                     
  2013                                          Adequate       1      0       0        0             0       1
  Inadequate or no vaccination                  \<1            0      0       0        2             0       6
  \>1                                           0              0      2       1        1                     
  2014                                          Adequate       0      1       0        2             0       3
  Inadequate or no vaccination                  \<1            0      0       0        2             0       8
  \>1                                           1              0      0       4        1                     
  2015                                          Adequate       0      2       5        0             0       7
  Inadequate or no vaccination                  \<1            2      2       12       1             2       32
  \>1                                           3              2      6       2        0                     
